 |
Press Releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
03/22/2022
Nearly 600 clinicians participated in a first-of-its-kind global consensus process supported by a grant from Cardinal Health; key findings include recommendation for use of mechanical compression...
03/17/2022The incise drape is the first to feature Avery Dennison's patented BeneHold™ CHG adhesive technology DUBLIN, Ohio, March 17, 2022 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today launched the...
-
02/25/2022
46 of 49 Eligible States and Over 90 Percent of Litigating Political Subdivisions Participate CONSHOHOCKEN, Pa. & DUBLIN, Ohio & IRVING, Texas--(BUSINESS WIRE)--AmerisourceBergen (NYSE: ABC),...
02/17/2022Cue's highly accurate COVID-19 molecular tests will now be available through the expansive Cardinal Health distribution network with reach to hospitals, pharmacies, and non-clinical consumer marketsToday Cue Health Inc. (Nasdaq: HLTH), a healthcare technology company, and Cardinal Health (NYSE: CAH) announced expanded distribution of Cue's professional use and over-the-counter COVID-19...
02/10/2022Cardinal Health (NYSE: CAH) has been recognized by Forbes as one of America's Best Large Employers 2022, a list of more than 500 public and private corporations, hospitals, universities and more,...
02/09/2022Cardinal Health (NYSE: CAH) today announced it will leverage the Kinaxis® RapidResponse® platform to increase medical product visibility and supply chain agility. Kinaxis will enhance Cardinal...
-
02/08/2022
Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved a quarterly dividend of $0.4908 per share. The dividend will be payable on April 15, 2022 to shareholders of record...
02/07/2022New report includes research findings on insulin biosimilars use among retail pharmacists and physiciansToday Cardinal Health published its 2022 Biosimilars Report: The U.S. Journey and Path Ahead, a publication that brings together the latest industry data on biosimilar utilization and payer...
-
02/03/2022- Revenue increased 9% to $45.5 billion
Cardinal Health (NYSE: CAH) today reported second quarter fiscal year 2022 revenues of $45.5 billion, an increase of 9% from the second quarter of last year. Second quarter GAAP operating loss was...
-
01/27/2022
Cardinal Health again has earned the perfect score of 100% on the Human Rights Campaign Foundation's Corporate Equality Index (CEI), a national benchmarking tool to measure corporate policies and...
01/10/2022- Mayo Clinic and Kaiser Permanente also contributed to over-subscribed investment roundMedically Home today announced a new, $110 million round of funding from strategic investors including Baxter International Inc., Global Medical Response (GMR) and Cardinal Health who will each...
-
01/10/2022
Cardinal Health (NYSE: CAH) today provided a fiscal year 2022 financial update for the Medical segment. The company now expects additional inflationary impacts and lower volumes resulting...
-
01/03/2022
Cardinal Health (NYSE: CAH) plans to release second-quarter financial results for its fiscal year 2022 on February 3 prior to the opening of trading on the New York Stock Exchange. The company...
- 12/22/2021
CONSHOHOCKEN, Pa. & DUBLIN, Ohio & IRVING, Texas--(BUSINESS WIRE)-- AmerisourceBergen (NYSE: ABC), Cardinal Health (NYSE: CAH) and McKesson (NYSE: MCK) announced today that the deadline for...
12/20/2021FDA Approves Telix’s Prostate Cancer Imaging Product, Illuccix®Melbourne (Australia) and Indianapolis, IN (U.S.A.) – 20 December 2021. Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company), a global biopharmaceutical company focused on the...
11/18/2021New offering automates previously manual supply tasks, enabling clinical lab staff to focus on patient careCardinal Health today announced its business, WaveMark™ Supply Management and Workflow Solutions, will now be available for implementation in clinical labs across the U.S. "WaveMark is among the...
11/16/2021Operation will deliver healthcare supplies on-demand to pharmacies, helping mitigate risk of stock-outs and improving accessKannapolis, NC—Nov. 16, 2021 – Cardinal Health (NYSE: CAH) and Zipline, the global leader in instant logistics, today announced a collaboration to offer on-demand autonomous aircraft delivery...
-
11/09/2021- Revenue increased 13% to $44.0 billion
Cardinal Health (NYSE: CAH) today reported first quarter fiscal year 2022 revenues of $44.0 billion, an increase of 13% from the first quarter of last year. First quarter GAAP operating earnings...
-
11/04/2021
Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved a quarterly dividend of $0.4908 per share. The dividend will be payable on January 15, 2022 to shareholders of...
10/28/2021Cardinal Health will explore how to better standardize real world evidence for use in regulatory decisionsCardinal Health (NYSE: CAH) announced today it has been awarded a $750,000 contract by the U.S. Food and Drug Administration (FDA) to implement an 18-month real world evidence (RWE) study as part...
10/26/2021Paoli, PA — Cardinal Health Specialty Solutions and Gastrologix, the only gastroenterology (GI)-specific group purchasing organization (GPO) in the United States, working in conjunction with the...
10/14/2021Journey Biosciences, Inc., a biotechnology company with an innovative proactive diagnostic screening technology for high risk kidney complications, including Diabetic Kidney Disease (DKD), today...
10/12/2021Cardinal Health (NYSE: CAH) announced today its Strategic Stock Solution now serves nearly 40 hospitals and health systems nationwide, just one year after its launch. In October last year, the...
-
09/28/2021
CONSHOHOCKEN, Pa. & DUBLIN, Ohio & IRVING, Texas--(BUSINESS WIRE)--AmerisourceBergen (NYSE: ABC), Cardinal Health (NYSE: CAH) and McKesson (NYSE: MCK) announced today that they have reached an...
